Skip to main content

Treatment Clinical Trials for Breast Cancer

Review the breast cancer treatment clinical trials on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 401-425 of 480

Abemaciclib Dose Escalation to Maintain Intensity (ADE-MI)
Status: Active
Location: 2 locations
Effect of HSD3B1 (1245C) Gene Mutation on Treatment of Stage I-III Breast Cancer
Status: Active
Location: Fred Hutch/University of Washington/Seattle Children's Cancer Consortium, Seattle, Washington
An Investigational Surgical Procedure (Vascularized Lymph Node Transfer) in Reducing the Risk of Lymphedema in Patients with Breast Cancer Undergoing Breast Reconstruction
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
Guided Meditation for the Reduction of Anxiety during Radiation Therapy for Patients with Breast and Gynecological Cancers, Med-RT BG
Status: Active
Location: Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah
A Structured Behavioral Intervention to Improve Patient Engagement and Health Outcomes in Invasive Breast Cancer Patients, Carolina Breast Cancer Study Phase 4 (CBCS4) Trial
Status: Active
Location: UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina
Semiconductor-Embedded Fabric Headbands for the Improvement of Cancer-Related Cognitive Impairment in Breast and Gynecologic Cancer Patients who have Completed Chemotherapy, HEADBAND Trial
Status: Active
Location: Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah
Repetitive Transcranial Magnetic Stimulation for Chemotherapy-Induced Peripheral Neuropathy in Breast and Gynecologic Cancer Survivors
Status: Active
Location: Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah
Telerehabilitation Cognitive Impairments Following Chemotherapy Feasibility Study
Status: Active
Location: Bright Cloud International Corp, Brunswick, New Jersey
RNA Expression and Molecular Subtype Analysis to Optimize Novel Therapy for Metastatic Breast Cancer, HARMONY Study
Status: Active
Location: UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina
A Skills-based Intervention for Promoting Resilience in Stress Management for Patients with Metastatic Breast Cancer, PRISM-MBC Trial
Status: Active
Location: UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina
Exercise Intervention for Reducing Fatigue in Patients with Locally Advanced, Unresectable or Metastatic Breast Cancer being Treated with Enhertu, ENERGIZE Trial
Status: Active
Location: Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah
Evaluating Biomarker Driven Early Therapeutic Selection in Patients With HR + HER2 - Metastatic or Unresectable Breast Cancer
Status: Active
Location: Siteman Cancer Center at Washington University, Saint Louis, Missouri
Cognitive Rehabilitation Following Breast Cancer Treatment
Status: Active
Location: MU Health - University Hospital/Ellis Fischel Cancer Center, Columbia, Missouri
Stereotactic Ablative Body Radiotherapy for the Treatment of ER Positive, HER2 negative Breast Cancer in Older Women not Undergoing Surgery, CARMEN Trial
Status: Active
Location: University of Kansas Cancer Center, Kansas City, Kansas
Safety and Feasibility of Robotic Single-Port Nipple Sparing Mastectomy.
Status: Active
Location: UT Southwestern/Simmons Cancer Center-Dallas, Dallas, Texas
Cryoablation Compared to Lumpectomy for the Treatment of Patients with Breast Cancer, COOL-IT Trial
Status: Active
Location: Siteman Cancer Center at Washington University, Saint Louis, Missouri
Harmonic Motion Imaging-Guided Focused Ultrasound Surgery for the Treatment of Breast Tumors
Status: Active
Location: NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York, New York
Amplitude-Modulated Radiofrequency Electromagnetic Field Therapy for the Treatment of Patients with Locally Advanced, Unresectable, or Metastatic Hormone Receptor Positive HER2 Negative Breast Cancer who Progressed on Previous Therapy
Status: Active
Location: Wayne State University/Karmanos Cancer Institute, Detroit, Michigan
Tumor Treating Fields for the Treatment of Leptomeningeal Metastases of the Spine in Patients with Breast or Lung Cancer
Status: Active
Location: Mayo Clinic in Florida, Jacksonville, Florida
Time-Restricted Eating and Cancer: Clinical Outcomes, Mechanisms, and Moderators
Status: Active
Location: University of Alabama at Birmingham Cancer Center, Birmingham, Alabama
Accelerator Based Stereotactic Body Radiation Therapy after Surgery in Treating Patients with Early Stage Breast Cancer
Status: Active
Location: University of Alabama at Birmingham Cancer Center, Birmingham, Alabama
A Precision Oncology Navigation and Expert Review Intervention for Improving Referral to Genome Informed Therapy among Patients with Stage IV Lung, Colorectal, Breast or Bladder Cancers, PROGRESS Trial
Status: Active
Location: UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina
BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease
Status: Active
Location: See ClinicalTrials.gov
Combined Immunotherapies in Metastatic ER+ Breast Cancer
Status: Active
Location: UPMC Hillman Cancer Center Erie, Erie, Pennsylvania
Tesetaxel as First-line Therapy for Metastatic Breast Cancer
Status: Active
Location: See ClinicalTrials.gov